Treatment Pattern in Patients with Stage III Non-Small-Cell Lung Cancer (NSCLC) in South China

被引:0
作者
Au, J. S. [1 ]
机构
[1] Hong Kong Adventist Hosp Oncol Ctr, Hong Kong, Peoples R China
关键词
multidisciplinary approach; Immunotherapy; stage III nonsmall cell lung cancer;
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
P09.40
引用
收藏
页码:S308 / S308
页数:1
相关论文
共 50 条
[41]   Tecemotide in unresectable stage III non-small-cell lung cancer in the phase III START study: updated overall survival and biomarker analyses [J].
Mitchell, P. ;
Thatcher, N. ;
Socinski, M. A. ;
Wasilewska-Tesluk, E. ;
Horwood, K. ;
Szczesna, A. ;
Martin, C. ;
Ragulin, Y. ;
Zukin, M. ;
Helwig, C. ;
Falk, M. ;
Butts, C. ;
Shepherd, F. A. .
ANNALS OF ONCOLOGY, 2015, 26 (06) :1134-1142
[42]   Prognostic and predictive value of neutrophil-to-lymphocyte ratio with adjuvant immunotherapy in stage III non-small-cell lung cancer [J].
Bryant, Alex K. K. ;
Sankar, Kamya ;
Strohbehn, Garth W. W. ;
Zhao, Lili ;
Elliott, David ;
Qin, Angel ;
Yentz, Sarah ;
Ramnath, Nithya ;
Green, Michael D. D. .
LUNG CANCER, 2022, 163 :35-41
[43]   MET in Non-Small-Cell Lung Cancer (NSCLC): Cross 'a Long and Winding Road' Looking for a Target [J].
Spitaleri, Gianluca ;
Aliaga, Pamela Trillo ;
Attili, Ilaria ;
Del Signore, Ester ;
Corvaja, Carla ;
Corti, Chiara ;
Uliano, Jacopo ;
Passaro, Antonio ;
de Marinis, Filippo .
CANCERS, 2023, 15 (19)
[44]   CONCURRENT CHEMORADIATION (CCHRT) FOR STAGE III NON-SMALL CELL LUNG CANCER (NSCLC): A PHASE II STUDY FROM THE GALICIAN LUNG CANCER GROUP [J].
Casal, Joaquin ;
Ponte, C. ;
Senin, C. ;
Campos, B. ;
Firvida, Xl ;
Carmona, M. ;
Hernandez, E. ;
Lopez, Md ;
Formoso, I. ;
Lazaro, M. ;
Vazquez, S. ;
Areses, Mc ;
Rodriguez, C. ;
Pena, C. ;
Villanueva, Mj .
JOURNAL OF THORACIC ONCOLOGY, 2013, 8 :S849-S849
[45]   A REVIEW ON CURRENT TREATMENT OPTIONS AND EVOLUTION OF TREATMENT STRATEGIES FOR PATIENTS WITH NON-SMALL CELL LUNG CANCER (NSCLC) [J].
Vesangikeerthivaishnavi ;
Tekulashivasai ;
Doranalaharshini ;
Sreenivaspasulai .
INTERNATIONAL JOURNAL OF LIFE SCIENCE AND PHARMA RESEARCH, 2020, :220-223
[46]   Bone metastases and immunotherapy in patients with advanced non-small-cell lung cancer [J].
Landi, Lorenza ;
D'Inca, Federica ;
Gelibter, Alain ;
Chiari, Rita ;
Grossi, Francesco ;
Delmonte, Angelo ;
Passaro, Antonio ;
Signorelli, Diego ;
Gelsomino, Francesco ;
Galetta, Domenico ;
Giannarelli, Diana ;
Parra, Hector Soto ;
Minuti, Gabriele ;
Tiseo, Marcello ;
Migliorino, Maria Rita ;
Cognetti, Francesco ;
Toschi, Luca ;
Bidoli, Paolo ;
Piantedosi, Francovito ;
Calabro, Luana ;
Cappuzzo, Federico .
JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2019, 7 (01)
[47]   Growth and functional reactivity of lymphocytes obtained from three anatomic compartments in patients with non-small-cell lung cancer (NSCLC) [J].
Yannelli, JR ;
Hirscowitz, E ;
Wroblewski, JM .
CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS, 2003, 18 (05) :735-749
[48]   Consolidation systemic treatment after radiochemotherapy for unresectable stage III non-small cell lung cancer [J].
Skrzypski, Marcin ;
Jassem, Jacek .
CANCER TREATMENT REVIEWS, 2018, 66 :114-121
[49]   Implementation of immunotherapy in the treatment of advanced non-small cell lung cancer (NSCLC) [J].
Tsiara, Anna ;
Liontos, Michalis ;
Kaparelou, Maria ;
Zakopoulou, Roubini ;
Bamias, Aristotelis ;
Dimopoulos, Meletios-Athanasios .
ANNALS OF TRANSLATIONAL MEDICINE, 2018, 6 (08)
[50]   Treatment outcome and toxicity of intensity-modulated (chemo) radiotherapy in stage III non-small cell lung cancer patients [J].
Stephanie LA Govaert ;
Esther GC Troost ;
Olga CJ Schuurbiers ;
Lioe-Fee de Geus-Oei ;
Ariën Termeer ;
Paul N Span ;
Johan Bussink .
Radiation Oncology, 7